IL6 and breast carcinoma: Furthermore, the interleukin-6 ligand (IL-6) which was recently shown to be a principal regulator of Stat3 activation in breast cancer [6], was found to be elevated in both MCF10A-Ras and MMTV-K-Ras tumors.